Polyphenols in the Treatment for Neuroinflammation-Induced Neurodegenerative Disease
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".
Deadline for manuscript submissions: closed (25 June 2024) | Viewed by 7598
Special Issue Editors
Interests: amyloid aggregation; autophagy; natural polyphenols; neurodegenerative diseases
Special Issues, Collections and Topics in MDPI journals
Interests: bioactive natural products; inflammation; oxidative stress; polyphenols; cell migration; autophagy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neuroinflammation is defined as an inflammatory response within the brain or spinal cord. This inflammation is mediated by the production of cytokines, chemokines, reactive oxygen species, and secondary messengers. These mediators are produced by resident CNS glia (microglia and astrocytes), endothelial cells, and peripherally derived immune cells. There are immune, physiological, biochemical, and psychological consequences of these neuroinflammatory responses. Moreover, the degree of neuroinflammation depends on the context, duration, and course of the primary stimulus or insult. In recent years, neuroinflammation has attracted particular interest, and genetic variants of molecules associated with ‘‘microgliopathies’’ result in increased risk of developing neurodegenerative disorders and cognitive decline. Current therapies for neurodegenerative disorders treat symptoms and final manifestations, including aggregate build-up, memory loss, behavioral changes, and sleep deficits; however, this strategy is not a sustainable approach to appropriate management of disease onset or progression. One of the more promising approaches considers the inhibition of amyloid formation by small-molecule inhibitors; however, multiple failures of clinical therapeutic approaches indicate that the current strategies must be modulated and emphasize the importance of targeting pre-symptomatic signs as oxidative stress and inflammation. Both oxidative stress and neuroinflammation preside over the symptomology of neurodegenerative disorders, and each promotes neurotoxic environments associated with neurodegeneration.
In this scenario, polyphenols represent a promising starting point for new preventive and therapeutic approaches, since they target effectively and simultaneously inflammatory and oxidative pathways, and amyloid aggregation. These molecules have worldwide availability, low cost, and low toxicity. Improved knowledge of these topics is mandatory to promote the use of natural polyphenols well beyond their known antioxidant, antidiabetic, and antilipidemic effects. Increased information in this sense could be exploited to enrich, from a commercial and nutraceutical point of view, the alimentary and healthy value of natural compounds.
Dr. Manuela Leri
Dr. Marzia Vasarri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
